A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy

ConditionProstate Cancer Patients Treated by Radiotherapy

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age18+

SponsorUniversity Hospital Schleswig-Holstein

About this trial

The primary goal of this study is to assess the impact of an app that reminds patients treated with hypofractionated radiotherapy (HF-RT) for prostate cancer to drink water prior to each radiotherapy session on the number of bladder volumes \<200 ml during the HF-RT course and to demonstrate that this number is lower than without using an app (historical control group).

Eligibility criteria

Qualifiers

Histologically proven prostate cancer

Indication for definitive HF-RT

Possession of and ability to use a smartphone

Bladder volume at CT-simulation <200 ml

Disqualifiers

Radiotherapy of pelvic lymph nodes

Expected non-compliance

Trial design

Treatments tested in this trial

Reminder App

Treatment groups

27 Participants

are divided into 1 treatment group

Locations

Denmark

Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark7100, VejleSouthern Denmark, Denmark

Germany

Medical Practice for Radiotherapy and Radiation Oncology30161, HanoverLower Saxony, Germany

Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein23562, LübeckSchleswig-Holstein, Germany

Spain

Radiation Oncology Department, Hospital Universitario Cruces/Biobizkaia Health Research Institute University of the Basque Country48903, BarakaldoBasque Country, Spain

Sponsors and collaborators

University Hospital Schleswig-Holstein

Lead sponsor

University of Southern Denmark

Collaborator

University of the Basque Country (UPV/EHU)

Collaborator

Source ClinicalTrials.gov